Results 171 to 180 of about 31,914 (284)

Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association

Circulation, 2017
A. Raval, J. Cigarroa, M. Chung, Larry J Diaz-Sandoval, D. Diercks, J. Piccini, Hee Soo Jung, J. Washam, B. Welch, A. Zazulia, S. Collins   +10 more
semanticscholar   +1 more source

Trends in Off-Label Indications of Non-Vitamin K Antagonist Oral Anticoagulants in Acute Coronary Syndrome. [PDF]

Rev Cardiovasc Med, 2023
Kaddoura R, Orabi B, Yassin MA, Omar AS.
europepmc   +1 more source

Direct oral anticoagulants or warfarin for A fib? [PDF]

, 2017
A recent study evaluated the effectiveness of 3 direct oral anticoagulants and warfarin in patients with atrial fibrillation. So which agents came out on top?
Lyon, Corey, Prasad, Shailendra, Reed, Alex   +2 more
core  

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.

Journal of the American College of Cardiology, 2016
B. Steinberg, P. Shrader, L. Thomas, J. Ansell, G. Fonarow, B. Gersh, P. Kowey, K. Mahaffey, G. Naccarelli, J. Reiffel, D. Singer, E. Peterson, J. Piccini   +12 more
semanticscholar   +1 more source

Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide

, 2016
Hematology; Surgery ...
Shantsila, Eduard, Lip, Gregory YH
openaire   +3 more sources

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Stroke, 2017
M. Cha, E. Choi, Kyungdo Han, So-Ryoung Lee, W. Lim, Seil Oh, G. Lip   +6 more
semanticscholar   +1 more source

Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism. [PDF]

BMC Med, 2023
Yoon D, Jeong HE, Park S, You SC, Bang SM, Shin JY.   +5 more
europepmc   +1 more source

How to Optimize the Administration of Low-Dose Non-vitamin K Antagonist Oral Anticoagulants in Everyday Practice? [PDF]

Anatol J Cardiol, 2022
Undas A.
europepmc   +1 more source

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment. [PDF]

Sci Rep, 2023
Lee HJ, Kim HK, Kim BS, Han KD, Park CS, Rhee TM, Park JB, Lee H, Kim YJ.   +8 more
europepmc   +1 more source

Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence.

Europace, 2015
B. Vrijens, H. Heidbuchel
semanticscholar   +1 more source